NHS-Approved Treatment Protocol

    Botox for Chronic Migraine Treatment

    Master evidence-based botulinum toxin administration for chronic migraine management. Comprehensive training for medical practitioners covering injection protocols, dosing guidelines, and patient care.

    31 Injection Sites

    Precise anatomical targeting across seven key muscle groups

    155-195 Units

    Standardised NHS-approved dosing protocol

    Foundation Training

    All essential skills covered in our comprehensive course

    Understanding Botox for Chronic Migraine

    Botulinum toxin type A (Botox) represents a revolutionary advance in preventive migraine therapy, offering significant relief for patients suffering from chronic migraine—defined as experiencing 15 or more headache days per month, with at least 8 days being migraine-related.

    NHS Approval and Clinical Evidence

    The National Institute for Health and Care Excellence (NICE) approved Botox for chronic migraine prophylaxis in June 2012, following extensive clinical trials that demonstrated significant efficacy and safety.

    • PREEMPT trials: Two Phase III studies involving over 1,384 patients showed Botox reduced headache days by 8-9 days per month
    • Long-term efficacy: Studies demonstrate sustained benefit over 2+ years of treatment with excellent tolerability
    • Quality of life: Significant improvements in headache impact, functional disability, and depression scores
    • Safety profile: Well-tolerated with minimal systemic side effects; local injection site reactions most common

    Ready to Transform Your Practice?

    Join hundreds of medical practitioners who've mastered Botox techniques for both aesthetic and therapeutic applications.

    2 Days
    Intensive training with live models
    Expert
    Taught by leading practitioners
    Full Support
    Lifetime access to mentoring
    AI